Literature DB >> 9402955

Association of transferrin C2 allele with late-onset Alzheimer's disease.

K Namekata1, M Imagawa, A Terashi, S Ohta, F Oyama, Y Ihara.   

Abstract

Transferrin (Tf), an iron-transporting protein, has many variants, but C1 and C2 variants account for the majority of the population in all races. Since Tf is reported to be immunocytochemically detectable in senile plaques in Alzheimer's disease (AD), we have examined the Tf allele frequency among AD patients. The C2 allele frequency in late-onset AD patients is significantly higher than that in age-matched controls. Unexpectedly, the C2 allele frequency in AD patients homozygous for the ApoE epsilon 4 allele is markedly increased, i.e., it is twice as high as that in the remaining AD patients carrying zero or one copy of the epsilon 4 allele.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9402955     DOI: 10.1007/s004390050600

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  22 in total

1.  Reduced Cerebral White Matter Integrity Assessed by DTI in Cognitively Normal H63D-HFE Polymorphism Carriers.

Authors:  Mark D Meadowcroft; Jianli Wang; Carson J Purnell; Paul J Eslinger; Elizabeth B Neely; Qing X Yang; James R Connor
Journal:  J Neuroimaging       Date:  2017-08-03       Impact factor: 2.486

Review 2.  Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.

Authors:  Daniel Krewski; Robert A Yokel; Evert Nieboer; David Borchelt; Joshua Cohen; Jean Harry; Sam Kacew; Joan Lindsay; Amal M Mahfouz; Virginie Rondeau
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2007       Impact factor: 6.393

3.  Suggestive synergy between genetic variants in TF and HFE as risk factors for Alzheimer's disease.

Authors:  J S K Kauwe; S Bertelsen; K Mayo; C Cruchaga; R Abraham; P Hollingworth; D Harold; M J Owen; J Williams; S Lovestone; J C Morris; A M Goate
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-06-05       Impact factor: 3.568

4.  Analysis of the effect of aluminum in drinking water and transferrin C2 allele on Alzheimer's disease.

Authors:  V Rondeau; A Iron; L Letenneur; D Commenges; F Duchêne; B Arveiler; J-F Dartigues
Journal:  Eur J Neurol       Date:  2006-09       Impact factor: 6.089

5.  HFE mutations and transferrin C1/C2 polymorphism among Croatian patients with schizophrenia and schizoaffective disorder.

Authors:  Alena Buretić-Tomljanović; Jadranka Vraneković; Gordana Rubeša; Suzana Jonovska; Draško Tomljanović; Vesna Sendula-Jengić; Miljenko Kapović; Smiljana Ristić
Journal:  Mol Biol Rep       Date:  2011-06-04       Impact factor: 2.316

6.  Butyrylcholinesterase is complexed with transferrin in chicken serum.

Authors:  E Weitnauer; C Ebert; F Hucho; A Robitzki; C Weise; P G Layer
Journal:  J Protein Chem       Date:  1999-02

7.  Quantitation of amyloid beta-protein (A beta) in the cortex during aging and in Alzheimer's disease.

Authors:  H Funato; M Yoshimura; K Kusui; A Tamaoka; K Ishikawa; N Ohkoshi; K Namekata; R Okeda; Y Ihara
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

Review 8.  A review of epidemiologic studies on aluminum and silica in relation to Alzheimer's disease and associated disorders.

Authors:  Virginie Rondeau
Journal:  Rev Environ Health       Date:  2002 Apr-Jun       Impact factor: 3.458

9.  Synergy between the C2 allele of transferrin and the C282Y allele of the haemochromatosis gene (HFE) as risk factors for developing Alzheimer's disease.

Authors:  K J H Robson; D J Lehmann; V L C Wimhurst; K J Livesey; M Combrinck; A T Merryweather-Clarke; D R Warden; A D Smith
Journal:  J Med Genet       Date:  2004-04       Impact factor: 6.318

10.  Effects of hemochromatosis and transferrin gene mutations on peripheral iron dyshomeostasis in mild cognitive impairment and Alzheimer's and Parkinson's diseases.

Authors:  S Mariani; M Ventriglia; I Simonelli; G Spalletta; S Bucossi; M Siotto; F Assogna; J M Melgari; F Vernieri; R Squitti
Journal:  Front Aging Neurosci       Date:  2013-08-05       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.